跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIJUVA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIJUVA
Authorized
STANDARD
BIJUVA
knight therapeutics inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
828b6030b7bfe778
Company
knight therapeutics inc.
Type
Standard
Approval Details
Approval Id
828b6030b7bfe778
Drug Approval Canada Name
BIJUVA
Product Name
BIJUVA
Status
Marketed
Status Date
2024-01-31
Original Market Date
2024-01-31
Din
02505223
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:32.00
Atc Original
G03FA04 PROGESTERONE AND ESTROGEN
Atc Name
g 03 fa 04
Aig Number
0254135003
Company Name
knight therapeutics inc.
Company Address
1055, 3400 De Maisonneuve Blvd W, Montreal, Quebec, Canada, H3Z 3B8
Active Ingredients
PROGESTERONE
100 MG
ESTRADIOL (ESTRADIOL HEMIHYDRATE)
1 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
828b6030b7bfe778
Type
Standard
Back to Health Canada Approvals